CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-06 | de los Pinos Elisabet See Remarks | Option exercise 10b5-1 | +3,800 | $2.74 | $10K | 184,740 |
| 2023-11-06 | de los Pinos Elisabet See Remarks | Sale 10b5-1 | −7,449 | $12.03 | $90K | 177,291 |
| 2023-11-06 | de los Pinos Elisabet See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,800 | 361,163 | ||
| 2023-11-06 | Feder Julie B Chief Financial Officer | Option exercise 10b5-1 | +3,900 | $2.74 | $11K | 73,500 |
| 2023-11-06 | Feder Julie B Chief Financial Officer | Sale 10b5-1 | −3,900 | $12.07 | $47K | 69,600 |
| 2023-11-06 | Feder Julie B Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,900 | 85,757 | ||
| 2023-11-01 | Hopkins Janet Jill Chief Medical Officer | Grant or award | +135,000 | 135,000 | ||
| 2023-11-01 | Hopkins Janet Jill Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-10-30 | Feder Julie B Chief Financial Officer | Sale | −3,385 | $6.82 | $23K | 69,600 |
| 2023-10-30 | de los Pinos Elisabet See Remarks | Sale | −9,586 | $6.83 | $65K | 180,940 |
| 2023-10-04 | Johnson David Michael Director | Purchase | +6,566 | $8.61 | $57K | 50,066 |
| 2023-10-03 | Johnson David Michael Director | Purchase | +13,500 | $8.27 | $112K | 43,500 |
| 2023-06-07 | Mattessich Antony C. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-06-07 | Johnson David Michael Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-06-07 | PAREKH RAJESH B Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-06-07 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-01-19 | Feder Julie B Chief Financial Officer | Grant or award | +48,750 | 72,985 | ||
| 2023-01-19 | Feder Julie B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-01-19 | De Rosch Mark Chief Operating Officer | Grant or award | +42,250 | 58,635 | ||
| 2023-01-19 | De Rosch Mark Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 |
Page 8 of 11 · 219 trades